Human heart fatty acid binding protein assay kit (immunoturbidimetric method) - NMPA Registration 皖械注准20172400078
Access comprehensive regulatory information for Human heart fatty acid binding protein assay kit (immunoturbidimetric method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 皖械注准20172400078 and owned by Anhui Daqian Bio-Engineering Limited Company. The device was approved on January 17, 2022.
This page provides complete registration details including registrant information, province location (Anhui), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
It is used for the quantitative determination of the content of human heart fatty acid-binding protein (H-FABP) in human serum in vitro.
用于体外定量测定人血清中人体心脏脂肪酸结合蛋白（H-FABP）的含量。
R1: buffer, polyethylene glycol R2: buffer, human heart fatty acid binding protein antibody latex particle calibration solution, quality control: human heart fatty acid binding protein (optional)
R1：缓冲液、聚乙二醇R2：缓冲液、人体心脏脂肪酸结合蛋白抗体乳胶颗粒校准液、质控品：人体心脏脂肪酸结合蛋白(可选)
Store in 2°C~8°C in the dark.
于2℃~8℃避光密封保存。